Volume 76, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


To study the relationship between micronutrient malnutrition and schistosomiasis mansoni, a cross-sectional study was undertaken involving 421 schoolchildren (mean age 12.6 years; 333 from schistosomiasis mansoni–endemic villages (Workemado and Sille) and 88 non-endemic controls from Sheno). Prevalence of schistosomiasis mansoni infection in Workemado and Sille was comparable (90.6% versus 95%, respectively), and prevalence of PPF in Workemado was significantly higher than in Sille (7.0% versus 0.6%, < 0.001). Compared with non-endemic controls, serum retinol concentrations were significantly lower and hydroperoxides were significantly higher in subjects from schistosomiasis mansoni–endemic areas. Furthermore, serum α-tocopherol concentrations in subjects from an area with high prevalence of PPF were significantly reduced while the concentrations in subjects from an area with low prevalence of PPF were comparable to the levels found in non-endemic healthy controls. In conclusion, micronutrient malnutrition and oxidative stress are associated with infection and levels of schistosomal PPF.


Article metrics loading...

Loading full text...

Full text loading...



  1. Chitsulo L, Engels D, Monttresor A, Savioli L, 2000. The global status of schistosomiasis and its control. Acta Trop 77 : 41–51.
  2. World Health Organization, 2002. Prevention and Control of Schistosomiasis and Soil-Transmitted Helminthiasis. WHO Technical Report Series, No. 912. Geneva: WHO.
  3. UNICEF, 2004. Micronutrient Initiative—Vitamin and Mineral Deficiency: A Global Progress Report. New York: UNICEF. Available at: http://www.micronutrient.org/reports/reports/Full_e.pdf. Accessed December 10, 2005.
  4. Boisier P, Ramarokoto CE, Ravoniarimbinina P, Rabarijaona L, Ravaoalimalala VE, 2001. Geographic differences in hepatosplenic complications of schistosomiasis mansoni and explanatory factors of morbidity. Trop Med Int Health 6 : 699–706.
  5. Booth M, Vennervald BJ, Kabatereine NB, Kazibwe F, Ouma JH, Kariuki CH, Muchiri E, Kadzo H, Ireri E, Kimani G, Mwatha JK, Dunn DW, 2004. Hepatosplenic morbidity in two neighbouring communities in Uganda with high levels of Schistosoma mansoni infection but with very different duration of residence. Trans R Soc Trop Med Hyg 98 : 125–136.
  6. Mohamed-Ali Q, Elwali NE, Abdelhameed AA, Mergani A, Rahoud S, Elagib KE, Saeed OK, Abel L, Magzoub MM, Dessein AJ, 1999. Susceptibility to periportal (Symmers) fibrosis in human Schistosoma mansoni infections: evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression. J Infect Dis 180 : 1298–1306.
  7. Dessein AJ, Hillaire D, Elwali NE, Marquet S, Mohamed-Ali Q, Mirghani A, Nenri S, Abdelhameed AA, Saeed OK, Magzoub MM, Abel L, 1999. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene. Am J Hum Genet 65 : 709–721.
  8. Chevillard C, Moukoko CE, Elwali NE, Bream JH, Kouriba B, Argiro L, Rahoud S, Mergani A, Henri S, Gaudart J, Mohamed-Ali Q, Young HA, Dessein AJ, 2003. IFN-gamma polymorphisms (IFN-gamma +2109 and IFN-gamma +3810) are associated with severe hepatic fibrosis in human hepatic schistosomiasis (Schistosoma mansoni). J Immunol 171 : 5596–5601.
  9. Mentink-Kane MM, Cheever AW, Thompson RW, Hari DM, Kabatereine NB, Vennervald BJ, Ouma JH, Mwatha JK, Jones FM, Donaldson DD, Grusby MJ, Dunne DW, Wynn TA, 2004. IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis. Proc Natl Acad Sci USA 101 : 586–590.
  10. Wynn TA, Thompson RW, Cheever AW, Mentink-Kane MM, 2004. Immunopathogenesis of schistosomiasis. Immunol Rev 201 : 156–167.
  11. Chiaramonte MG, Cheever AW, Malley JD, Donaldson DD, Wynn TA, 2001. Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. Hepatology 34 : 273–282.
  12. de Jesus AR, Magalhaes A, Miranda DG, Miranda RG, Araujo MI, de Jesus AA, Silva A, Santana LB, Pearce E, Carvalho EM, 2004. Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection. Infect Immun 72 : 3391–3397.
  13. Alves Oliveira LF, Moreno EC, Gazzinelli G, Martins-Filho OA, Silveira AM, Gazzinelli A, Malaquias LC, LoVerde P, Leite PM, Correa-Oliveira R, 2006. Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans. Infect Immun 74 : 1215–1221.
  14. Henri S, Chevillard C, Mergani A, Paris P, Gaudart J, Camilla C, Dessein H, Montero F, Elwali NE, Saeed OK, Magzoub M, Dessein AJ, 2002. Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease. J Immunol 169 : 929–936.
  15. Mwatha JK, Kimani G, Kamau T, Mbugua GG, Ouma JH, Mumo J, Fulford AJC, Jones FM, Butterworth AE, Roberts MB, Dunne DW, 1998. High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-γ, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni. J Immunol 160 : 1992–1999.
  16. Friedman SL, 2000. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275 : 2247–2250.
  17. Parola M, Robino G, 2001. Oxidative stress-related molecules and liver fibrosis. J Hepatol 35 : 297–306.
  18. Poli G, 2000. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 21 : 49–98.
  19. King MR, Ismail AS, Davis LS, Karp DR, 2006. Oxidative stress promotes polarization of human T cell differentiation toward a T-helper 2 phenotype. J Immunol 176 : 2765–2772.
  20. Gharib B, Abdallahi OM, Dessein A, De-Reggi M, 1999. Development of eosinophil peroxidase activity and concomitant alteration of the antioxidant defences in the liver of mice infected with Schistosoma mansoni. J Hepatol 30 : 594–602.
  21. Abdallahi OMS, Hanna S, De-Reggi M, Gharib B, 1999. Visualization of oxygen radical production in mouse liver in response to infection with Schistosoma mansoni. Liver 19 : 495–500.
  22. El-Sokkary GH, Omar HM, Hassanein AMM, Cuzzocrea S, Reiter RJ, 2002. Melatonin reduces oxidative damage and increases survival of mice infected with Schistosoma mansoni. Free Radic Biol Med 32 : 319–332.
  23. Hanna S, Gharib B, Lepidi H, 2005. Experimental schistosomiasis, protective aspects of granulomatous reaction in the mouse liver. Parasitol Res 96 : 6–11.
  24. Friis H, Ndhlovu P, Kaondera K, Sandstrom B, Michaelsen KF, Vennervald BJ, Christensen NO, 1996. Serum concentration of micronutrients in relation to schistosomiasis and indicators of infection: a cross-sectional study among rural Zimbabwean schoolchildren. Eur J Clin Nutr 50 : 386–391.
  25. Friis H, Mwaniki D, Omondi B, Muniu E, Magnussen P, Geissler W, Thiong’o F, Michaelsen KF, 1997. Serum retinol concentrations and Schistosoma mansoni, intestinal helminths, and malarial parasitemia: a cross-sectional study in Kenyan pre-school and primary school children. Am J Clin Nutr 66 : 665–671.
  26. Pascal M, Abdallahi OMS, Elwali NE, Mergani A, Quarashi MA, Magzoub MA, de Reggi M, Gharib B, 2000. Hyaluronate levels and markers of oxidative stress in the serum of Sudanese subjects at risk of infection with Schistosoma mansoni. Trans R Soc Trop Med Hyg 94 : 66–70.
  27. Eboumbou C, Steghens JP, Abdallahi OMS, Mirghani A, Gallian P, van Kappel A, Quarashi A, Gharib B, De Reggi M, 2005. Circulating markers of oxidative stress and liver fibrosis in Sudanese subjects at risk of schistosomiasis and hepatitis. Acta Trop 94 : 99–106.
  28. Peters PA, El Alamy M, Warren KS, Mahmoud AA, 1980. Quick Kato smear for field quantitation of Schistosoma mansoni eggs. Am J Trop Med Hyg 29 : 217–219.
  29. Berhe N, Medhin G, Erko B, Smith T, Gedamu S, Bereded D, Moore R, Habte E, Redda A, Gebre-Michael T, Gundersen SG, 2004. Variations in helminth faecal egg counts in Kato-Katz thick smears and their implications in assessing infection status with Schistosoma mansoni. Acta Trop 92 : 205–212.
  30. World Health Organization, 2000. Ultrasound in Schistosomiasis: A Practical Guide to the Standardized use of Ultrasonography for the Assessment of Schistosomiasis-Related Morbidity, No. TDR/STR/SCH/00.1.TDR/WHO. Geneva: WHO. Available at: http://www.who.int/tdr/publications/publications/pdf/ultrasound.pdf. Accessed December 10, 2005.
  31. Berhe N, Geitung JT, Medhin G, Gundersen SG, 2006. Large scale evaluation of WHO’s ultrasonographic staging system of schistosomal periportal fibrosis in Ethiopia. Trop Med Int Health 11 : 1286–1294.
  32. Cesarone MR, Belcaro G, Carratelli M, Cornelli U, De Sanctis MT, Incandela L, Barsotti A, Terranova R, Nicolaides A, 1999. A simple test to monitor oxidative stress. Int Angiol 18 : 127–130.
  33. Morrissey PA, Sheehy PJA, 1999. Optimal nutrition: vitamin E. Proc Nutr Soc 58 : 459–468.
  34. Christian P, Schulze K, Stoltzfus RJ, West KP Jr, 1998. Hypore-tinolemia, illness symptoms, and acute phase protein response in pregnant women with and without night blindness. Am J Clin Nutr 67 : 1237–1243.
  35. Stephensen CB, Gildengorin G, 2000. Serum retinol, acute phase response, and the apparent misclassification of vitamin A status in the third National Health and Nutrition Examination Survey. Am J Clin Nutr 72 : 1170–1178.
  36. Thurnham DI, McCabe GP, Northrop-Clewes CA, Nestel P, 2003. Effects of sub-clinical infection on plasma retinol concentrations and assessment of prevalence of vitamin A deficiency: meta-analysis. Lancet 362 : 2052–2058.
  37. Davis TM, Garcia-Webb P, Fu LC, Spencer JL, Beilby J, Guo XB, 1993. Antioxidant vitamins in acute malaria. Trans R Soc Trop Med Hyg 87 : 596–597.
  38. Das BS, Thurnham DI, Das DB, 1996. Plasma alphatocopherol, retinol, and carotenoids in children with falciparum malaria. Am J Clin Nutr 64 : 94–100.
  39. Metzger A, Mukasa G, Shankar AH, Ndeezi G, Melikian G, Semba RD, 2001. Antioxidant status and acute malaria in children in Kampala, Uganda. Am J Trop Med Hyg 65 : 115–119.
  40. Nussenblatt V, Mukasa G, Metzger A, Ndeezi G, Eisinger W, Semba RD, 2002. Relationship between carotenoids and anaemia during acute uncomplicated Plasmodium falciparum malaria in children. J Health Popul Nutr 20 : 205–214.
  41. Ahmed F, Mohiduzzaman M, Jackson AA, 1993. Vitamin A absorption in children with ascariasis. Br J Nutr 69 : 817–825.
  42. Mwaniki D, Omondi B, Muniu E, Thiong’o F, Ouma J, Magnussen P, Geissler PW, Michaelsen KF, Friis H, 2002. Effects on serum retinol of multi-micronutrient supplementation and multi-helminth chemotherapy: a randomised, controlled trial in Kenyan school children. Eur J Clin Nutr 56 : 666–673.
  43. Solomons NW, Bulux J, 1997. Identification and production of local carotene-rich foods to combat vitamin A malnutrition. Eur J Nutr 51 : S39–S45.
  44. Tontisirin K, Nantel G, Bhattacharjee L, 2002. Food-based strategies to meet the challenges of micronutrient malnutrition in the developing world. Proc Nutr Soc 61 : 243–250.
  45. Bouis HE, 2003. Micronutrient fortification of plants through plant breeding: can it improve nutrition in man at low cost? Proc Nutr Soc 62 : 403–411.
  46. Amde T, Stroud A, Aune J, 2004. Advancing human nutrition without degrading land resources through modeling cropping systems in the Ethiopian highlands. Food Nutr Bull 25 : 344–353.
  47. Abuye C, Urga K, Knapp H, Selmar D, Omwega AM, Imungi JK, Winterhalter P, 2003. A compositional study of Moringa stenopetala leaves. East Afr Med J 80 : 247–252.
  48. Makonnen E, Hunde A, Damecha G, 1997. Hypoglycaemic effect of Moringa stenopetala aqueous extract in rabbits. Phytother Res 11 : 147–148.
  49. Svilaas A, Sakhi AK, Andersen LF, Svilaas T, Strom EC, Jacobs DR Jr, Ose L, Blomhoff R, 2004. Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J Nutr 134 : 562–567.
  50. Wolde-Gebriel Z, Demeke T, West CE, 1991. Xerophthalmia in Ethiopia: a nationwide ophthalmological, biochemical and anthropometric survey. Eur J Clin Nutr 45 : 469–478.
  51. Haidar J, Tsegaye D, Mariam DH, Tibeb HN, Muroki NM, 2003. Vitamin A supplementation on child morbidity. East Afr Med J 80 : 17–21.
  52. Kassaye T, Receveur O, Johns T, Beckake MR, 2001. Prevalence of vitamin A deficiency in children aged 6–9 years in Wukro, northern Ethiopia. Bull World Health Organ 79 : 415–422.
  53. Asrat YT, Omwega AM, Muita JW, 2002. Prevalence of vitamin A deficiency among pre-school and school-aged children in Arssi Zone, Ethiopia. East Afr Med J 79 : 355–359.

Data & Media loading...

  • Received : 20 Aug 2006
  • Accepted : 08 Dec 2006

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error